D-0862-2022 Class III Terminated
FDA drug recall D-0862-2022 was initiated by Fagron, Inc on Mar 4, 2022 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated Jul 14, 2024). Affected quantity: 58 containers.
Recall details
- Product Type
- Drugs
- Report Date
- May 18, 2022
- Initiation Date
- Mar 4, 2022
- Termination Date
- Jul 14, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 58 containers
Product description
Nandrolone Decanoate, USP, 100 g per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-04
Reason for recall
Subpotent Drug
Distribution pattern
Nationwide within the USA
Code information
Lot #: 18H02-U02-044979, 18H02-U02-046141, Exp. Date 10/31/2022; 18L12-U02-050309,18L12-U02-000953, 18L12-U02-A009829, Exp. Date Sep 2023.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0862-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026